Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease.
Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease.
复制标题
镰状细胞病儿童脑动脉血流速度的个体内差异。
DOI:
10.1002/pbc.21142
复制
发表时间:
2007
影响因子:
3.2
通讯作者:
Adams,RobertJ
中科院分区:
文献类型:
--
作者:
Brambilla,DonaldJ;Miller,ScottT;Adams,RobertJ
BackgroundChildren with sickle cell disease (SCD) are at elevated risk of stroke. Risk increases with blood flow velocity in selected cerebral arteries, as measured by transcranial Doppler (TCD) ultrasound, and use of TCD to screen these patients is widely recommended. Interpretation of TCD results should be based on knowledge of intra‐individual variation in blood flow velocity, information not currently available for sickle cell patients.ProceduresBetween 1995 and 2002, 4,141 subjects, 2–16 years old, with homozygous SCD or Sβ0‐thalasemmia and no history of stroke were screened with TCD, including 2,018 subjects screened in one clinical trial (STOP), 1,816 screened in another (STOP 2), and 307 screened in an interim ancillary prospective study. The 812 subjects with ≥2 examinations <6 months apart were selected for analysis, including 242 (29.8%) subjects with normal average velocities (i.e., <170 cm/sec), 350 (43.1%) subjects with conditional velocities (i.e., 170–199 cm/sec), and 220 (27.1%) subjects with abnormal velocities (i.e., ≥200 cm/sec). The intra‐subject standard deviation of TCD velocity was estimated from the difference between velocities at the first two interpretable examinations on each subject.ResultsAn intra‐subject standard deviation of 14.9 cm/sec was obtained. Seven (0.9%) subjects had unusually large and unexplained differences between velocities at the two examinations (range of absolute differences: 69–112 cm/sec).ConclusionsWhile stroke risk is well demonstrated to increase with increasingly abnormal TCD velocity, given the relatively large intra‐subject variability, one TCD examination is generally not sufficient to characterize stroke risk in this patient population. Pediatr Blood Cancer 2007;49:318–322. © 2007 Wiley‐Liss, Inc.